Versican Plus Bb Oral Lyophilisate and Solvent for Oral Suspension for Dogs

Vaccinate healthy animals only.

Special precautions for safe use in the target species:
The veterinary medicinal product contains live bacteria and must be administered by
the oral route only. Parenteral administration can generate abscesses and cellulitis.
Vaccinated dogs may excrete the vaccine strain of Bordetella bronchiseptica
35 days oronasally and for at least 70 days in faeces following vaccination.
Due to the attenuated nature of the vaccine strain it is not necessary to keep
unvaccinated dogs separate from vaccinated dogs. However during this time, it is
advised that immunocompromised dogs avoid contact with vaccinated dogs.
The Bordetella bronchiseptica in the veterinary medicinal product has been shown to
be safe in pigs exposed to the vaccine strain (e.g. from contact with vaccinated
dogs). Cats exposed to the vaccine strain (e.g. from contact with vaccinated dogs)
may show moderate clinical signs such as sneezing, nasal and ocular discharge.
Safety of the bacteria in the veterinary medicinal product shed by vaccinated dogs
has not been studied in other animal species.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals:
Disinfect hands and equipment after use.
In case of accidental self-injection during reconstitution of the veterinary medicinal
product, seek medical advice immediately and show the package leaflet or the label
to the physician.
Persons administering the veterinary medicinal product to the dog should be aware
that repeated exposure to the veterinary medicinal product may lead to rare
hypersensitivity reactions.
Immunocompromised persons are advised to avoid contact with the veterinary
medicinal product and vaccinated dogs during the oronasal shedding period.
Special precautions for the protection of the environment:
Not applicable.